Am Fam Physician. 2025;112(4):450-451
Author disclosure: No relevant financial relationships.
CLINICAL QUESTION
Is use of nicotine e-cigarettes an effective strategy for tobacco smoking cessation?
EVIDENCE-BASED ANSWER
Use of nicotine e-cigarettes increases tobacco smoking cessation rates compared with use of nicotine replacement therapy (NRT), non-nicotine e-cigarettes, behavioral support only, and no support. (Strength of Recommendation [SOR]: A, Cochrane review, systematic review, meta-analysis of five randomized controlled trials [RCTs], and a large RCT.) Nicotine e-cigarettes are as effective as varenicline (Chantix) for tobacco smoking cessation at 26 weeks, but the effect may wane over time. (SOR: B, single-site RCT.)
EVIDENCE SUMMARY
A 2024 Cochrane review analyzed 88 studies, including 47 RCTs, eight randomized crossover trials, and 33 uncontrolled cohort studies (N = 27,235). The review evaluated the effectiveness of nicotine e-cigarettes for tobacco smoking cessation vs conventional NRT (eg, nicotine gums, nicotine transdermal patches), varenicline, non-nicotine e-cigarettes, heated tobacco products, behavioral support only, and no support. The adults involved in the review smoked cigarettes and had varying levels of motivation to quit smoking.1
Subscribe
From $180- Immediate, unlimited access to all AFP content
- More than 125 CME credits/year
- AAFP app access
- Print delivery available
Issue Access
$59.95- Immediate, unlimited access to this issue's content
- CME credits
- AAFP app access
- Print delivery available